Orai1 Antibodies

Santa Cruz Biotechnology offers a broad range of Orai1 monoclonal antibodies for research in cellular calcium signaling. Orai1 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Orai1 functions as a key component of the store-operated calcium entry (SOCE) pathway, regulating calcium influx in response to depletion of calcium stores in the endoplasmic reticulum. Orai1 maintains essential physiological processes, including muscle contraction, immune response, and cell proliferation. Research focused on Orai1 continues to reveal its significance in various diseases, including cancer and autoimmune disorders. Scientists worldwide rely on advanced research tools to investigate calcium signaling pathways and their impact on cellular function. Studying Orai1 helps unlock new insights into calcium-dependent cellular processes and their regulation. Understanding Orai1's role in calcium homeostasis advances knowledge of both normal physiology and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific understanding of calcium signaling pathways and their impact on human health.